Industry veteran with extensive experience in key areas of focus Interim-CFO Richard Narido to focus on HOPE Therapeutics acquisition opportunities WILMINGTON, Del., Nov. 18, 2024 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback